PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia, Prostate and Breast Cancers from National Cancer Institute
November 08, 2021 08:30 ET
|
PDS Biotechnology Corporation
Advances Next Phase of Versamune® Oncology Pipeline FLORHAM PARK, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company...
Quoin Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with AFT Pharmaceuticals for its Lead Asset, QRX003
November 08, 2021 08:00 ET
|
Quoin Pharmaceuticals, Inc.
AFT Gains Exclusive Rights to Commercialize QRX003 in Australia and New Zealand ASHBURN, Va., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”),...
Abaxx Technologies Affiliated Company, Base Carbon Corp., Announces a $50 Million Brokered Private Placement Financing
November 05, 2021 10:37 ET
|
Abaxx Technologies Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc., (NEO:ABXX) (OTCQX:ABXXF) (“Abaxx” or the...
CryptoCompare, ein Anbieter von Daten für digitale Assets, erhält FCA-Zulassung
November 05, 2021 08:14 ET
|
CryptoCompare
LONDON, Nov. 05, 2021 (GLOBE NEWSWIRE) -- CryptoCompare, der führende Anbieter von Marktdaten und -indexen für digitale Assets, hat die Zulassung der Financial Conduct Authority (FCA) erhalten und...
Sprott Asset Management Enters Agreement with North Shore Indices, Inc. to Acquire Licensing Rights to the Index Tracked by the North Shore Global Uranium Mining ETF
November 04, 2021 14:53 ET
|
Sprott Inc.
TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott”) (NYSE/TSX: SII) announced today that Sprott Asset Management LP (“Sprott Asset Management”), a wholly-owned subsidiary of Sprott,...
Digital Asset Data Provider CryptoCompare Receives FCA Authorisation
November 04, 2021 08:00 ET
|
CryptoCompare
LONDON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- CryptoCompare, the leading digital asset market data and index provider, has received authorisation from the Financial Conduct Authority (FCA) and is now...
Aptose Enters into Exclusive Worldwide License Agreement with Hanmi Pharmaceutical for Clinical-Stage Myeloid Kinome Inhibitor HM43239
November 04, 2021 06:00 ET
|
Aptose Biosciences, Inc.
HM43239 delivers multiple complete responses (CRs) in diverse R/R AML patients Aptose to host conference call and webcast today at 9:00 am ET SAN DIEGO and TORONTO and SEOUL, South Korea, Nov. 04,...
Mountain Valley MD Holdings Completes Licensing Agreement With Red White and Bloom Brands Inc.
November 02, 2021 08:45 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce, further to its news release dated...
Skyharbour Signs Option Agreement with Medaro Mining Corp to Option the Yurchison Uranium Project
November 02, 2021 07:30 ET
|
Skyharbour Resources Ltd
VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that it...
PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune-based Universal Flu Vaccine
November 01, 2021 08:30 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...